PTEN and AKT/GSK-3β/CRMP-2 signaling pathway are involved in neuronal apoptosis and axonal injury in early brain injury after SAH in rats
Hong Chen,Chao Zhou,Jianfeng Zheng,Zhaosi Zhang,Yongbing Deng,Chongjie Cheng,Zongduo Guo,Gang Huo,Cheng Yin,Xiaochuan Sun
DOI: https://doi.org/10.1016/j.gendis.2020.05.002
2022-01-01
Abstract:<p>In early brain injury (EBI) after subarachnoid hemorrhage (SAH), white matter (WM) axonal injury plays a key role in the prognosis of the disease. The purpose of this study was to investigate the effects of phosphatase and tensin homolog deleted on chromosome ten (PTEN) on axonal injury and neuronal apoptosis post-SAH in rats and to find its underlying mechanism. Adeno-associated virus was injected into the lateral ventricle to suppress or promote PTEN. Neural function post-SAH in animals was determined by the modified Garcia score, beam balance, and Rotarod test, and the blood-brain barrier disruption was assessed by the brain water content. Axonal injury post-SAH was observed by transmission electron microscopy (TEM) and determined by immunofluorescence staining (IF), and neuron apoptosis was measured by TUNEL staining. The mechanism was analyzed by Western blot (WB) to detect phosphorylated-PTEN (p-PTEN)/PTEN, p-AKT/AKT, p-glycogen synthase kinase 3β (p-GSK-3β)/GSK-3β, p-collapsin response mediator protein-2 (p-CRMP-2)/CRMP-2, axonal injury marker β-APP and pro- and anti-apoptosis protein, including Bax and Bcl-2, expression. We found that 1. After knocking down PTEN, neuronal apoptosis and axonal injury were alleviated, and nerve function and blood-brain barrier were protected; accordingly, after overexpression of PTEN, neuronal apoptosis and axon damage were aggravated, and nerve function damage and blood-brain barrier damage were increased. 2. PTEN and AKT/GSK-3β/CRMP-2 pathway were jointly involved in regulating neuronal apoptosis and WM axon injury after SAH. According to our research, PTEN was a negative factor of EBI, and together with the AKT/GSK-3β/CRMP-2 signaling pathway aggravates neuronal apoptosis and WM axon damage after SAH. Inhibition of PTEN expression may become a new target for SAH treatment.</p>
genetics & heredity,biochemistry & molecular biology